Company intelligence / Profile preview

Valence Labs

Montreal, Quebec, Canadavalencelabs.com ↗

Ownership: Private
Employees: ~51
Development stage: Preclinical

Overview

Valence Labs, powered by Recursion, is an advanced AI research engine focused on accelerating drug discovery through computational modeling of biological systems. It has developed state-of-the-art models such as TxPert. The India-based entity specializes in GMP-compliant API manufacturing with no direct involvement in clinical development.

Therapeutic areas: Immunology
Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Partnerships

Collaborations with biotech partners

Beyond the preview

Go deeper on Valence Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valence Labs.

Explore the full profile